US FDA panel votes against diabetes implant due to safety concerns
22 Sep 2023 //
REUTERS
i2o Therapeutics Names Kurt Graves Chairman and CEO, Announces Corporate Updates
28 Aug 2023 //
BUSINESSWIRE
i2O Therapeutics Announces Research Collaboration, Option Agreement with Janssen
06 Jan 2022 //
BUSINESSWIRE
i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral
10 Feb 2021 //
BUSINESSWIRE